Quidel Ortho Reagents, Consumables and Maintenance

SOL #: HT940826FE032Award Notice

Overview

Buyer

DEPT OF DEFENSE
Defense Health Agency (Dha)
DEFENSE HEALTH AGENCY
SAN ANTONIO, TX, 78230, United States

Place of Performance

GOULDS, FL

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

In Vitro Diagnostic Substances, Reagents, Test Kits And Sets (6550)

Set Aside

No set aside specified

Timeline

1
Posted
May 27, 2026

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Defense Health Agency (DHA) has awarded a Firm Fixed-Price contract to Quidel Ortho Sales Company, LLC for reagents, consumables, and maintenance services. This non-competitive award, justified by a Limited Sources Justification (LSJ) under FAR 8.401, supports the 96th Medical Group (MDG) laboratory at Eglin AFB, Florida, ensuring the continuous operation of their Quidel Ortho, Vision Swift Analyzers.

Scope of Work

The contract covers the provision of FDA-approved reagents and consumables specifically compatible with the existing Quidel Ortho, Vision Swift Analyzers. It also includes essential technical support and maintenance to ensure the reliable and continuous operation of these critical diagnostic systems.

Contract Details

  • Contract Type: Firm Fixed-Price
  • Awardee: Quidel Ortho Sales Company, LLC
  • Award Vehicle: Veteran Affairs Federal Supply Schedule
  • Duration: A base period of four months (June 1, 2026 - September 30, 2026), followed by four option years.
  • Set-Aside: Not applicable for this specific award, as it was awarded non-competitively based on a Limited Sources Justification. The government aims to encourage future small business participation.
  • Published Date: May 27, 2026

Justification for Award

This award was made on a non-competitive basis, as detailed in the attached redacted Limited Sources Justification. The justification cites the critical need for FDA-approved reagents and the Original Equipment Manufacturer (OEM) status of Quidel Ortho to ensure compatibility and proper functioning with the existing Vision Swift Analyzers. Market research, including a Request for Information (RFI) on SAM.gov, received only one industry response. The government plans to publish this award notice and the justification on the Government Point of Entry website to foster future competition and encourage small business involvement.

Contact Information

People

Points of Contact

Marcus MattinglyPRIMARY
Robby BrinkmannSECONDARY

Files

Files

Download

Versions

Version 1Viewing
Award Notice
Posted: May 27, 2026
Quidel Ortho Reagents, Consumables and Maintenance | GovScope